IMED

I-MED Pharma is a privately held Canadian pharmaceutical company specializing in the diagnosis and management of ocular surface diseases, particularly dry eye disease (DED). Founded in 1989 and headquartered in Montreal, the company provides a comprehensive range of solutions including diagnostic tools, ocular hygiene products, and advanced tear film substitutes. Their flagship product lines, such as I-DROP and I-LID 'N LASH, are widely utilized by eye care professionals globally to treat conditions like Meibomian Gland Dysfunction (MGD) and blepharitis. I-MED Pharma is recognized for its commitment to research and development in ophthalmology, focusing on innovative viscoadaptive formulations that enhance patient comfort and clinical outcomes.